July 2024
Savara Raises $100 Million Following Lung Disease Treatment Breakthrough
Savara, Lung Disease, $100 Million Raise, Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Treatment
Alumis Completes IPO, Raising $250 Million for Inflammation and Immunology Research
Alumis, IPO, Inflammation, Immunology, Biotech, TYK2 Inhibitor, Plaque Psoriasis, Uveitis, Lupus